Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)
CompletedPhase 4NCT00090181
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to evaluate the efficacy of MK0663 for the treatment of chronic low back pain and to investigate the overall safety and tolerability over four weeks of treatment.
Study details
- Official title
- A Double-Blind, Parallel-group, 4-Week Trial to Assess the Efficacy and Safety of Etoricoxib 60 mg and Diclofenac 150 mg in Patients With Chronic Low Back Pain
- Conditions
- Interventions
- Drug: MK0663, etoricoxib / Duration of Treatment: 4 weeks
- Drug: Comparator: diclofenac / Duration of Treatment: 4 weeks
- Sponsor
- Organon and Co
- Start date
- 2004-06
- Primary completion
- 2005-03
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Male and female patients 18 years of age or older, who have Chronic Low Back Pain after the discontinuation of their previous medication for their condition. * Patients should have at least 3 months of Low Back Pain.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00090181